VREX - Varex Imaging jumps 19% on upgrade due positive FQ2 guidance PT $41

Following the company's quarterly results, Oppenheimer analyst Suraj Kalia upgrades Varex Imaging ([[VREX]] +19.9%) to Outperform from Perform with a $41 price target.In a research note, the analyst cites substantial progress with internal OpEx and balance sheet improvement initiatives, exciting new products, and attractive valuation for the upgrade, and is further encouraged by medical's COVID recovery spreading to fluoroscopy, signaling rising general inpatient procedure volumes and higher utilization.Price target is $41; currently the stock trades at $23.59.FQ1 results show revenue beat consensus, more details here.Dive deep for Q2 guidance in company presentation.

For further details see:

Varex Imaging jumps 19% on upgrade due positive FQ2 guidance, PT $41